Zomedica Corp.
ZOMDF
$0.05
$0.014540.85%
| Weiss Ratings | ZOMDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ZOMDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ZOMDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.46 | |||
| Price History | ZOMDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 4.17% | |||
| 30-Day Total Return | -58.68% | |||
| 60-Day Total Return | -59.35% | |||
| 90-Day Total Return | -58.40% | |||
| Year to Date Total Return | -63.82% | |||
| 1-Year Total Return | -62.80% | |||
| 2-Year Total Return | -79.42% | |||
| 3-Year Total Return | -82.79% | |||
| 5-Year Total Return | -70.59% | |||
| 52-Week High % Change | -81.81% | |||
| 52-Week Low % Change | 135.10% | |||
| Price | ZOMDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.20 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Mar 05, 2025 | |||
| 52-Week High Price (Date) | May 16, 2024 | |||
| Valuation | ZOMDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 34.79M | |||
| Enterprise Value | -40.01M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.06 | |||
| Earnings Per Share Growth | 314.38% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.31 | |||
| Price/Book (Q) | 0.17 | |||
| Enterprise Value/Revenue (TTM) | -1.50 | |||
| Price | $0.05 | |||
| Enterprise Value/EBITDA (TTM) | 1.31 | |||
| Enterprise Value/EBIT | 1.05 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ZOMDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 979.95M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ZOMDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 734 369 2555 | |||
| Address | 100 Phoenix Drive Ann Arbor, MI 48108 | |||
| Website | www.zomedica.com | |||
| Country | United States | |||
| Year Founded | -- | |||
| Profitability | ZOMDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -143.14% | |||
| Profit Margin | -232.70% | |||
| Management Effectiveness | ZOMDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -9.78% | |||
| Return on Equity | -- | |||
| Income Statement | ZOMDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 26.73M | |||
| Total Revenue (TTM) | 26.73M | |||
| Revenue Per Share | $0.03 | |||
| Gross Profit (TTM) | 18.61M | |||
| EBITDA (TTM) | -30.45M | |||
| EBIT (TTM) | -38.26M | |||
| Net Income (TTM) | -62.19M | |||
| Net Income Avl. to Common (TTM) | -62.19M | |||
| Total Revenue Growth (Q YOY) | 10.24% | |||
| Earnings Growth (Q YOY) | -1,263.95% | |||
| EPS Diluted (TTM) | -0.06 | |||
| EPS Diluted Growth (Q YOY) | -1,260.00% | |||
| Balance Sheet | ZOMDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 76.88M | |||
| Cash Per Share (Q) | $0.08 | |||
| Total Current Assets (Q) | 87.27M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 202.84M | |||
| Current Ratio (Q) | 10.822 | |||
| Book Value Per Share (Q) | $0.21 | |||
| Total Assets (Q) | 214.12M | |||
| Total Current Liabilities (Q) | 8.06M | |||
| Total Debt (Q) | 2.08M | |||
| Total Liabilities (Q) | 11.27M | |||
| Total Common Equity (Q) | 202.84M | |||
| Cash Flow | ZOMDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 12.11M | |||
| Cash from Financing (TTM) | -70.00K | |||
| Net Change in Cash (TTM) | -12.04M | |||
| Levered Free Cash Flow (TTM) | -19.19M | |||
| Cash from Operations (TTM) | -24.12M | |||
